EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Roadmap for Studying the Impact of Pharmacist Board Certification on Patient Outcomes: Feasibility, Applicability, and Methodological Considerations

Robert J DiDomenico iD, Susan E Smith iD, Alexandre Chan iD, Zachary Dougherty iD, Kristin Griebe iD, Young R Lee iD, Brian Murray iD, Russel J Roberts iD, Emily T Shin iD, Josephine M Vonderhaar, Kyle A Weant iD

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026-02 · 9 (2)

DOI: 10.1002/jac5.70165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, online erschienen am 18.01.2026. Verfasst von Robert J DiDomenico und 10 weiteren Autor:innen. Beteiligte Einrichtung: Herbert M. and Carol H. Retzky College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Pharmacists, Certification, Pharmacy Service, Hospital, Outcome Assessment, Health Care. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American College of Clinical Pharmacy (ACCP) advocates for board certification of clinical pharmacists in one of the recognized specialties as a fundamental qualification and requirement for providing and supervising trainees in the provision of direct patient care. However, data linking pharmacist board certification to patient outcomes are limited, and many methodological challenges exist to effectively evaluate the impact of board‐certified pharmacists (BCPs). The purpose of this ACCP white paper is to critically analyze study design characteristics in order to inform future studies assessing the impact of BCPs on patient outcomes. Value depends on the stakeholder perspective, which informs the study design. This white paper considers the feasibility and applicability of various study methods that may be used to evaluate the impact of BCPs, including overall study design, study group assignment, outcome measures, reporting of clinical practice activities, identification of confounding variables, and statistical analyses, including methods to control for confounders. The 2025 ACCP Research Affairs Committee was surveyed to rate the feasibility and applicability of studying the impact of BCPs on outcomes by stakeholder perspective. Studies from the health care system or provider perspectives were rated as providing the best balance between feasibility and applicability, whereas various study design characteristics (e.g., prospective study designs, use of “length of” or disease‐related surrogate markers as primary outcomes, adjusting for specific confounders) were rated highly and are desirable for future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsCertificationPharmacy Service, HospitalOutcome Assessment, Health CareHumansFeasibility StudiesProfessional RoleResearch Design

Stichwörter der Autor:innen

board certificationpharmacistresearch methods

Autor:innen und Institutionen

  • Herbert M. and Carol H. Retzky College of Pharmacy, University of Illinois Chicago, Chicago, Illinois, USA.
  • College of Pharmacy, University of Georgia, Athens, Georgia, USA.
  • School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, Irvine, California, USA.
  • The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Henry Ford Health, Detroit, Michigan, USA.
  • Ben and Maytee Fisch College of Pharmacy, University of Texas at Tyler, Tyler, Texas, USA.

ORCID-Profile: Robert J DiDomenico, Susan E Smith, Alexandre Chan, Zachary Dougherty, Kristin Griebe, Young R Lee, Brian Murray, Russel J Roberts, Emily T Shin, Kyle A Weant

Zitieren

APA

DiDomenico, R. J., Smith, S. E., Chan, A., Dougherty, Z., Griebe, K., Lee, Y. R., Murray, B., Roberts, R. J., Shin, E. T., Vonderhaar, J. M., & Weant, K. A. (2026). A Roadmap for Studying the Impact of Pharmacist Board Certification on Patient Outcomes: Feasibility, Applicability, and Methodological Considerations. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 9(2). https://doi.org/10.1002/jac5.70165

Vancouver

DiDomenico RJ, Smith SE, Chan A, Dougherty Z, Griebe K, Lee YR, et al. A Roadmap for Studying the Impact of Pharmacist Board Certification on Patient Outcomes: Feasibility, Applicability, and Methodological Considerations. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2026;9(2). doi:10.1002/jac5.70165

BibTeX
@article{DiDomenico2026,
  author = {DiDomenico, Robert J and Smith, Susan E and Chan, Alexandre and Dougherty, Zachary and Griebe, Kristin and Lee, Young R and Murray, Brian and Roberts, Russel J and Shin, Emily T and Vonderhaar, Josephine M and Weant, Kyle A},
  title = {A Roadmap for Studying the Impact of Pharmacist Board Certification on Patient Outcomes: Feasibility, Applicability, and Methodological Considerations},
  journal = {JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY},
  year = {2026},
  volume = {9},
  number = {2},
  doi = {10.1002/jac5.70165}
}
Kostenlos starten →